Provided by Tiger Trade Technology Pte. Ltd.

LMP Capital and Income Fund Inc

15.56
+0.04000.26%
Volume:42.35K
Turnover:659.68K
Market Cap:355.67M
PE:5.54
High:15.62
Open:15.60
Low:15.50
Close:15.52
52wk High:16.18
52wk Low:13.79
Shares:22.86M
Float Shares:22.86M
Volume Ratio:0.64
T/O Rate:0.19%
Dividend:1.44
Dividend Rate:9.25%
EPS(TTM):2.81
EPS(LYR):-0.0358
ROE:19.14%
ROA:1.15%
PB:0.90
PE(LYR):-434.56

Loading ...

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

GlobeNewswire
·
May 06

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 05

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 05

Press Release: Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

Dow Jones
·
Apr 30

LMP Capital and Income Fund elects Agdern, Kamerick, Mason as Class III directors

Reuters
·
Apr 29

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026

GlobeNewswire
·
Apr 27

Press Release: Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors

Dow Jones
·
Apr 27

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

GlobeNewswire
·
Apr 23

LMP Capital and Income Fund updates portfolio management team effective May 1, 2026

Reuters
·
Apr 17

LMP Capital and Income Fund files Form 3 for CCO-subadviser Kim Stout

Reuters
·
Apr 08

LMP Capital & Income Fund files Form 3 for John Haller, Dir./COO-Subadviser

Reuters
·
Apr 03

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine

GlobeNewswire
·
Apr 02

Press Release: Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

Dow Jones
·
Mar 31

Press Release: Emmaus Life Sciences Reports Annual Financial Results

Dow Jones
·
Mar 31

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

GlobeNewswire
·
Mar 30

Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 26

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 23

MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease

GlobeNewswire
·
Mar 19

Press Release: SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Dow Jones
·
Mar 19

LMP Capital and Income Fund Inc. Announces Annual Stockholders Meeting

Reuters
·
Mar 10